PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 112 filers reported holding PMV PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23 | -4.2% | 3,811 | 0.0% | 0.00% | – |
| Q2 2023 | $24 | +33.3% | 3,811 | 0.0% | 0.00% | – |
| Q1 2023 | $18 | -56.1% | 3,811 | -18.3% | 0.00% | – |
| Q4 2022 | $41 | -99.9% | 4,665 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $56,000 | -15.2% | 4,665 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $66,000 | -25.8% | 4,665 | +9.2% | 0.00% | 0.0% |
| Q1 2022 | $89,000 | – | 4,271 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
| Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
| OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
| Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
| Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
| Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
| Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
| RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
| HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |